| # | Drug | Count |
|---|---|---|
| 0 | FULVESTRANT | 8 |
| 1 | PALBOCICLIB | 8 |
| 2 | ADALIMUMAB | 7 |
| 3 | DENOSUMAB | 5 |
| 4 | ERGOCALCIFEROL | 5 |
| 5 | METHOTREXATE SODIUM | 5 |
| 6 | METHADONE | 4 |
| 7 | METHOTREXATE | 4 |
| 8 | METOCLOPRAMIDE | 4 |
| 9 | METOCLOPRAMIDE HYDROCHLORIDE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM IODIDE I 123 | 1 | 0.0011 |
| 1 | SODIUM IODIDE I 131 | 1 | 0.0010 |
| 2 | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES | 1 | 0.0006 |
| 3 | CERITINIB | 1 | 0.0004 |
| 4 | SULINDAC | 1 | 0.0004 |
| 5 | AMIFAMPRIDINE PHOSPHATE | 1 | 0.0003 |
| 6 | DONANEMAB-AZBT | 1 | 0.0003 |
| 7 | CALCITONIN SALMON | 1 | 0.0003 |
| 8 | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | 1 | 0.0003 |
| 9 | FULVESTRANT | 8 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Calcitonin [EPC] | 1 | 0.0003 |
| 1 | Estrogen Receptor Antagonist [EPC] | 8 | 0.0002 |
| 2 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 3 | Glinide [EPC] | 1 | 0.0001 |
| 4 | Interleukin-17A Antagonist [EPC] | 4 | 0.0001 |
| 5 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 6 | Barbiturate [EPC] | 1 | 0.0001 |
| 7 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 8 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 9 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |